Provided By GlobeNewswire
Last update: Dec 5, 2025
SINGAPORE, Dec. 05, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or “the Company”), a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that it entered into a securities purchase agreement on November 26, 2025 with Streeterville Capital, LLC, a Utah limited liability company, for the sale of a convertible warrant (the “Warrant”) for an aggregate purchase price of US$100,000. The Warrant is exercisable for up to 2,000,000 newly issued EUDA ordinary shares (the “Warrant Shares”) at an exercise price of US$6.00 per share and is being offered pursuant to the Company’s effective shelf registration statement on Form F-3 (File No. 333-282723) and a related prospectus supplement.
Read more at globenewswire.com